Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- 2019 Novel Coronavirus Infection
- Adult Respiratory Distress Syndrome
- COVID-19 Virus Infection
- Respiratory Distress Syndrome, Adult
- SARS Coronavirus 2 Infection
- SARS CoV-2 Infection
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04778059
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Sairam Parthasarathy, MD The University of Arizona Health Sciences Center/ Banner Healthcare Systems Hospitals
Get Well Soon